7 results about "Disulfide bond reduction" patented technology

The application discloses a method for inhibiting the migration of toxic small molecules in plastics based on a protein-based phase transition composite coating, which is characterized by the following steps: inducing the rapid phase transition of proteins on the surface of plastics by a disulfide bond reducing agent to form a nanofilm, and adsorbing polysaccharides on the surface of the nanofilm to form a protein-based phase transition composite coating on the surface of the plastics, which can inhibit the migration of toxic small molecules in the plastics. The preparation method of the protein-based phase transition composite coating is simple, the cost is low, the inhibition effect on the migration of phthalate plasticizers and bisphenol A in plastics (such as PVC, PP, PE, PS and PET) is good, the adsorption of drugs on the surface of medical plastics can be prevented at the same time, the protein-based phase transition composite coating has good biocompatibility, is suitable for temperature-sensitive plastics, has universality, can be safely used on the surface of food and medical plastic products, and has a good popularization and application prospect on the surface of plastics.

The present invention is directed to a method of selectively reacting and removing disulfides and reducing corrosivity in petroleum matrixes with an acid wash composition.

The present disclosure provides compositions and methods for sample processing, particularly for oligonucleotide analysis e.g. analysis of formulated nucleic acid drugs. A composition for pretreating at least one target nucleic acid in a biological mixture provided herein includes a chaotropic agent selected from a substituted guanidine, a substituted amidine, a substituted quaternary amine, or a combination thereof, an optional protease, and / or an optional disulfide-reducing agent. Methods of analyzing at least one target nucleic acid in a biological mixture is also provided herein. Furthermore, the present disclosure provides methods for quantifying at least one target cationic lipid interacting with a nucleic acid.

This invention discloses a protein composite fiber membrane material with wet adhesion and drug delivery capabilities, and its preparation method. Protein, functional active ingredients, and a volatile conformational stabilizer are mixed and treated with a disulfide reducing agent to obtain a spinning solution. Electrospinning causes the conformational stabilizer to volatilize, while the protein maintains its untransformed conformation. Subsequently, a bioadhesive polymer interlayer is applied to the fiber membrane surface, followed by secondary spinning to form a sandwich-structured composite fiber membrane material. The material obtained by this invention undergoes a controllable conformational transition in a wet environment. The β-sheets and hydrophobic residues at the interface, in conjunction with the interlayer, disrupt the hydration barrier at the interface, achieving strong adhesion through multiple mechanisms and effectively resisting interference from dynamic physiological environments. Simultaneously, the co-spinning technology enables flexible loading and controlled release of functional molecules, providing a scalable technical platform for constructing composite patches with both physical isolation and active therapeutic functions, showing promising applications in tissue repair and drug delivery.

This invention provides a cell culture additive composition for preventing antibody disulfide bond reduction and its application, relating to the biopharmaceutical field. It comprises the following raw materials: a redox regulator, a metal ion chelator, an antioxidant, an adjuvant, and a cell protectant. This invention inhibits antibody disulfide bond reduction from multiple aspects through the synergistic effect of the redox regulator, metal ion chelator, antioxidant, and buffer. Specifically, the redox regulator maintains a suitable redox potential, the metal ion chelator removes harmful metal ions, the antioxidant removes free radicals, and the buffer maintains pH stability. The components work together synergistically to enhance the effect.

Described herein is a process using a novel composition for strengthening hair by crosslinking the free thiols naturally present on hair or resulting from the reduction of disulfide bonds in damaged or treated hair. The process involves applying a composition containing an active agent that interacts with free thiols present in hair, forming a covalent carbon-sulphur bond, thereby enhancing the structural integrity of hair. The present invention provides a rinse off or leave-in treatment that effectively reduces breakage and restores strength to weakened or damaged hair and helps in increased longevity of reshaped hair such as straightening or curling.

The invention discloses a protein electrostatic spinning fibrous membrane dressing for promoting scar-free healing of wounds. The protein electrostatic spinning fibrous membrane dressing comprises water-soluble globular protein, a disulfide bond reducing agent and a stabilizer (trifluoroethanol, a urea water solution, trifluoroacetic acid and the like). According to the dressing, disulfide bonds of water-soluble globular protein are broken through a disulfide bond reducing agent to form an expanded protein chain, and then the expanded protein chain is stabilized through a stabilizer; electrostatic spinning is carried out by controlling the direct-current voltage between the spray head and the roller receiver rotating at a high speed, the receiving distance and the rotating speed of the roller receiver, and the protein nanofiber membrane dressing with the oriented arrangement structure is prepared. The protein nanofiber membrane dressing inhibits excessive wound contraction by reducing expression of alpha-SMA, promotes wound healing at the same time, and has a remarkable anti-scar effect. The dressing has a wide application prospect in wound treatment, especially in clinical application of pursuing scar-free healing.